China National Medicines (600511.SS) Earnings Analysis
China National Medicines (600511.SS) next reports earnings on 2026-08-20. Trailing P/E 10.26.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 600511.SS next report earnings?
| Next earnings date | 2026-08-20 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | 13.86B |
600511.SS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-22 | 0.63 CNY | n/a | n/a | n/a |
| 2026-03-20 | 0.67 CNY | n/a | n/a | n/a |
| 2025-10-21 | 0.721 CNY | n/a | n/a | n/a |
| 2025-04-24 | 0.608 CNY | n/a | n/a | n/a |
| 2025-03-19 | 0.688 CNY | n/a | n/a | n/a |
| 2024-08-21 | 0.717 CNY | n/a | n/a | n/a |
600511.SS valuation and analyst view
| Trailing P/E | 10.26 |
|---|---|
| Trailing EPS | 2.666 CNY |
| Price / book | 1.09 |
| Dividend yield | 2.92% |
| Market cap | 20.79B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is China National Medicines (600511.SS)'s next earnings date?
China National Medicines is next scheduled to report on 2026-08-20 and revenue estimate of 13.86B.
Did 600511.SS beat earnings last quarter?
Consensus estimate data was not available for 600511.SS's 2026-04-22 report.
What is 600511.SS's current P/E ratio and EPS?
600511.SS trades at a trailing P/E of 10.26 on trailing EPS of 2.6664461007217892 CNY.
What do analysts rate 600511.SS?
600511.SS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.